Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals

Paul Gallagher, Pierre Olivier Lang, Antonio Cherubini, Eva Topinková, Alfonso Cruz-Jentoft, Beatriz Montero Errasquín, Pavla Mádlová, Beatrice Gasperini, Hilde Baeyens, Jean-Pierre Baeyens, Jean-Pierre Michel, Denis O'Mahony

. 2011 ; 67 (11) : 1175-1188.

Language English Country Germany

Document type Multicenter Study, Research Support, Non-U.S. Gov't

Grant support
NS10029 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK ProQuest Central from 1997-01-01 to 1 year ago
CINAHL Plus with Full Text (EBSCOhost) from 2008-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 1997-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-01-01 to 1 year ago

PURPOSE: Potentially inappropriate prescribing is common in older people presenting to hospital with acute illness in Ireland. The aim of this study was to determine if this phenomenon is unique to Ireland or whether it is a more widespread problem in hospitals across Europe. METHODS: Prospective data were collected from 900 consecutive older patients admitted to six university teaching hospitals (150 patients per centre) in Geneva (Switzerland), Madrid (Spain), Oostende (Belgium), Perugia (Italy), Prague (Czech Republic) and Cork (Ireland). Age, gender, comorbidity, cognitive status, prescription medicines taken before admission and baseline haematological, biochemical and electrocardiographic data were recorded. STOPP and Beers' criteria were applied to detect potentially inappropriate medicines (PIMs). START criteria were applied to detect potentially inappropriate prescribing omissions (PPOs). RESULTS: The overall PIM prevalence rate was 51.3% using STOPP criteria, varying from 34.7% in Prague to 77.3% in Geneva, and 30.4% using Beer's criteria, varying from 22.7% in Prague to 43.3% in Geneva. Using START criteria, the overall PPO prevalence rate was 59.4%, ranging from 51.3% in Cork to 72.7% in Perugia. Polypharmacy predicted the presence of PIMs using STOPP criteria [with>10 medications: odds ratio (OR)7.22, 95% confidence interval (CI) 4.30-12.12, p<0.001] and Beers' criteria (with>10 medications: OR4.87, 95% CI 3.00-7.90, p<0.001). Increasing co-morbidity (Charlson Index>2) and age>85 years significantly predicted PPOs. CONCLUSION: Potentially inappropriate drug prescribing and the omission of beneficial drugs are highly prevalent in acutely ill hospitalized older people in six European centres.

000      
00000naa a2200000 a 4500
001      
bmc14072562
003      
CZ-PrNML
005      
20190104111154.0
007      
ta
008      
140923s2011 gw f 000 0|eng||
009      
AR
035    __
$a (PubMed)21584788
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a gw
100    1_
$a Gallagher, Paul $u Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland. pfgallagher77@eircom.net
245    10
$a Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals / $c Paul Gallagher, Pierre Olivier Lang, Antonio Cherubini, Eva Topinková, Alfonso Cruz-Jentoft, Beatriz Montero Errasquín, Pavla Mádlová, Beatrice Gasperini, Hilde Baeyens, Jean-Pierre Baeyens, Jean-Pierre Michel, Denis O'Mahony
520    9_
$a PURPOSE: Potentially inappropriate prescribing is common in older people presenting to hospital with acute illness in Ireland. The aim of this study was to determine if this phenomenon is unique to Ireland or whether it is a more widespread problem in hospitals across Europe. METHODS: Prospective data were collected from 900 consecutive older patients admitted to six university teaching hospitals (150 patients per centre) in Geneva (Switzerland), Madrid (Spain), Oostende (Belgium), Perugia (Italy), Prague (Czech Republic) and Cork (Ireland). Age, gender, comorbidity, cognitive status, prescription medicines taken before admission and baseline haematological, biochemical and electrocardiographic data were recorded. STOPP and Beers' criteria were applied to detect potentially inappropriate medicines (PIMs). START criteria were applied to detect potentially inappropriate prescribing omissions (PPOs). RESULTS: The overall PIM prevalence rate was 51.3% using STOPP criteria, varying from 34.7% in Prague to 77.3% in Geneva, and 30.4% using Beer's criteria, varying from 22.7% in Prague to 43.3% in Geneva. Using START criteria, the overall PPO prevalence rate was 59.4%, ranging from 51.3% in Cork to 72.7% in Perugia. Polypharmacy predicted the presence of PIMs using STOPP criteria [with>10 medications: odds ratio (OR)7.22, 95% confidence interval (CI) 4.30-12.12, p<0.001] and Beers' criteria (with>10 medications: OR4.87, 95% CI 3.00-7.90, p<0.001). Increasing co-morbidity (Charlson Index>2) and age>85 years significantly predicted PPOs. CONCLUSION: Potentially inappropriate drug prescribing and the omission of beneficial drugs are highly prevalent in acutely ill hospitalized older people in six European centres.
590    __
$a bohemika - dle Pubmed
650    02
$a akutní nemoc $x epidemiologie $7 D000208
650    12
$a akutní nemoc $7 D000208
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a hodnocení spotřeby léčiv $x statistika a číselné údaje $x trendy $7 D017723
650    02
$a ženské pohlaví $7 D005260
650    02
$a zdravotní služby pro seniory $x normy $x statistika a číselné údaje $7 D006299
650    12
$a nemocnice univerzitní $x normy $x statistika a číselné údaje $7 D006785
650    02
$a lidé $7 D006801
650    02
$a nevhodné předepisování $x statistika a číselné údaje $x trendy $7 D057970
650    02
$a mužské pohlaví $7 D008297
650    12
$a léky na předpis $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D055553
650    02
$a prevalence $7 D015995
650    02
$a prospektivní studie $7 D011446
650    02
$a rizikové faktory $7 D012307
651    _2
$a Evropa $7 D005060
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lang, Pierre Olivier $u Rehabilitation and Geriatric Department, Geneva Medical School and University Hospitals, Geneva, Switzerland
700    1_
$a Cherubini, Antonio $u Department of Clinical and Experimental Medicine, Institute of Gerontology and Geriatrics, University of Perugia Medical School, Perugia, Italy
700    1_
$a Topinková, Eva, $d 1953- $7 nlk20020113720 $u Department of Geriatric Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cruz-Jentoft, Alfonso $u Department Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Madrid, Spain
700    1_
$a Montero Errasquín, Beatriz $u Department Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Madrid, Spain
700    1_
$a Mádlová, Pavla $7 xx0094458 $u Department of Geriatric Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Gasperini, Beatrice $u Department of Clinical and Experimental Medicine, Institute of Gerontology and Geriatrics, University of Perugia Medical School, Perugia, Italy
700    1_
$a Baeyens, Hilde $u Department of Geriatric Medicine, AZ Alma, Eeklo, Belgium
700    1_
$a Baeyens, Jean-Pierre $u Department of Geriatric Medicine, AZ Damiaan, Oostende, Belgium
700    1_
$a Michel, Jean-Pierre $u Rehabilitation and Geriatric Department, Geneva Medical School and University Hospitals, Geneva, Switzerland
700    1_
$a O'Mahony, Denis $u Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland
773    0_
$t European Journal of Clinical Pharmacology $x 0031-6970 $g Roč. 67, č. 11 (2011), s. 1175-1188 $w MED00001613
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140923153726 $b ABA008
991    __
$a 20190104111349 $b ABA008
999    __
$a ok $b bmc $g 1040407 $s 871452
BAS    __
$a 3
BMC    __
$a 2011 $b 67 $c 11 $d 1175-1188 $i 0031-6970 $m European journal of clinical pharmacology $x MED00001613 $n Eur J Clin Pharmacol
GRA    __
$a NS10029 $p MZ0
LZP    __
$a 2014-09/abme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...